Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jul 16, 2022; 14(7): 416-423
Published online Jul 16, 2022. doi: 10.4253/wjge.v14.i7.416
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
Mohammad Azam, Amit Hudgi, Pearl Princess Uy, Jinal Makhija, John Erikson L Yap
Mohammad Azam, Amit Hudgi, Department of Internal Medicine, Medical College of Georgia/Augusta University, Augusta, GA 30912, United States
Pearl Princess Uy, John Erikson L Yap, Division of Gastroenterology, Medical College of Georgia/Augusta University, Augusta, GA 30912, United States
Jinal Makhija, Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, United States
Author contributions: Azam MU and Hudgi AR performed the research, collected the data, wrote the paper, contributed to analysis and reviewed the article; Uy P collected the data and reviewed the article; Makhija J performed the formal analysis; Yap JE conceptualized, supervised the report and approved the final draft submitted.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Augusta University Medical Centre.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors declare that they have no conflict of interest.
Data sharing statement: The technical appendix, statistical code, and dataset are available from the corresponding author at Consent was not obtained as this was a retrospective study. No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: John Erikson L Yap, MD, Assistant Professor, Division of Gastroenterology, Medical College of Georgia/Augusta University, 1120 15th Street, Augusta, GA 30912, United States.
Received: February 28, 2022
Peer-review started: February 28, 2022
First decision: April 13, 2022
Revised: May 8, 2022
Accepted: June 15, 2022
Article in press: June 15, 2022
Published online: July 16, 2022
Core Tip

Core Tip: This single centered study highlights low adverse events of anti-angiogenics after endoscopic procedures. Currently, the consensus recommends holding anti-angiogenics 28 d prior to the procedure. This small sample study sheds light on the need to hold anti-angiogenics prior to endoscopic procedure and affirms to not delay emergent endoscopic procedures.